Real-time enrollment status for this brain cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:47 AM UTC
| NCT Number | NCT05768919 |
| Recruiting Status | Recruiting |
| Condition | Brain Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 2 sites in the US |
| Sponsor | SignPath Pharma, Inc. |
| Last Updated on CT.gov | November 29, 2024 (Nov 29, 2024) |
As of March 2, 2026: Clinical trial NCT05768919 is currently recruiting participants. This clinical trial study for brain cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by SignPath Pharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05768919 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05768919 was last updated Nov 29, 2024 (November 29, 2024). HelloStudys verifies this status automatically.